RGS RGS Healthcare Solutions

Healthcare tender results

Before your next bid, know who won and at what price for the healthcare tenders you bid on

RGS reads public healthcare tenders in 30 countries and shows who won, the published bid prices, and who holds and makes each product.

10M+ tenders and awards30 countriesUpdated daily

Tender data is public. Making sense of it is not

No price history

Who won, at what price and how far off you were is published, but nobody keeps it in one place.

No view across borders

Each country publishes in its own language and format, so the price next door stays unknown.

No time

Results get copied into Excel by hand, and re-tenders still arrive as surprises.

What your team sees on a Monday morning

The market narrowed to the products you sell: tenders coming due, price moves and changes in who wins. Screens below use demo data.

RGS platform: a personal overview with tenders coming due, price moves and winner changes for the user's products
Price per unit over time for one molecule, compared across six countries
Price per unit by quarter, side by side across markets
Tender calendar showing tendered volume falling due by quarter, with open and re-opening tenders
The tender calendar: what is open, running and due to re-open

Built on a decade of healthcare tender data

10M+

Healthcare tenders and awards in the database

24

Languages read, with notices searchable in English

30

Countries refreshed every day, with more markets connected on request

10+

Years of award history for price and competitor analysis

Who works with RGS

4

of Europe's leading generics manufacturers have used the RGS platform

Top 10

A top-10 global pharmaceutical company is an RGS client

Since 2026

A Dutch generics manufacturer that sells through partners runs its tender and pricing intelligence on RGS

Up to94%

Improvement in tender visibility

Up to44%

Increase in tender win rate reported by clients

Up to34%

Increase in annual tender revenue

Results reported by RGS clients. Individual outcomes depend on portfolio, markets and starting point.

How RGS works in practice

Pricing guidance, from our team

Price on what has actually won in comparable tenders

Built from awards for the same molecule, buyer type and lot structure.

  • Win probability across your price range
  • Expected value alongside win rate
  • Scenario comparison before you submit

Award and Price Intelligence

Who won, at what price, and how far off you were

All winning partners, their ranking and their prices where the evidence exists, including multi-partner awards.

  • Bidder prices, where the buyer publishes them
  • Distance to the winner on your own bids
  • The same molecule's price in neighbouring markets
Award detail in the RGS platform: three winners of one tender with their contract prices (demo data)

Regulatory intelligence

Who may sell it, who makes it, and who is coming next

Licence holders are linked to their parent group, so a new holder, a supplier switch or a competitor filing shows up straight away.

  • New holders, withdrawals and transfers on your molecules
  • Manufacturers and contract makers behind each holder
  • Pending filings and competitor portfolios

Numbers you can check before you rely on them

A sales manager who finds one wrong price stops using the tool. That is why each figure links back to its source notice.

  • Traceable

    Prices, winners and volumes can be traced back to the notice it came from.

  • Estimates labelled

    Stated volumes and our estimates are shown side by side, never blended into one number.

  • Strength by strength

    Prices are kept per strength and presentation, so tablets never dilute injectables.

  • Averages only with enough data

    A market average appears only where enough awards stand behind it.

  • Clear about gaps

    Some prices are never published. We show where, instead of filling the gap with a guess.

  • Checked by people

    Analysts review high-value tenders and awards by hand before they reach you.

Nobody has to feed it

Tenders, results and re-tender dates arrive by email and in the platform, routed to the right owner. No central spreadsheet.

Down to the single tender

Open a molecule and see the tenders behind it: lots, strengths, winner, prices and the next date.

Tender rules differ by country. Our guides explain how each market works

German insurers split awards across partners, Italian regions run their own frameworks and Nordic buyers tender nationally. Our country guides explain each route.

You talk to the founders

RGS is run by its two co-founders, Roel Sarelse and Stavros Therapontos. One of us runs each demo and stays involved after you sign, together with our engineering team.

Roel Sarelse
Roel SarelseCo-founder and CEO
Stavros Therapontos
Stavros TherapontosCo-founder and COO

Frequently asked questions

What does RGS Healthcare Solutions do?

RGS gives pharmaceutical and medtech companies one view of the tenders, marketing authorisations, manufacturing networks and competitors behind the molecules they sell. The platform finds and prices tenders, tracks who may sell and who makes each product, maps competitors and feeds supply chain planning. Alongside the software, our team can run bids, produce reports and support market entry.

How does tender matching work?

We collect tender notices and documents across Europe every day. Language models read each one, extract the products, lots, volumes, deadlines and award criteria, and match them to your portfolio by molecule, strength, presentation and market. Irrelevant notices are filtered out, and your feedback improves the matching over time.

Which countries does RGS cover?

All 27 EU member states are refreshed every day, together with the United Kingdom, Norway and Switzerland. Selected markets outside Europe are covered on request. Our Europe pages explain how procurement works in each major market.

Does RGS only cover tenders?

No. Alongside tenders, the platform tracks marketing authorisation holders, pending filings, manufacturing and batch release sites and competitor portfolios, and uses all of it for supply chain planning, profitability checks and supplier risk.

What is competitive intelligence for pharmaceutical tenders?

It is the analysis of who wins which tenders, at what price and on which criteria. RGS records awards at lot level, including multi-partner awards, which shows competitors' win rates by market and molecule, how prices have moved, and where the white space is.

How does pricing guidance find the right bid price?

Our models learn from historical awards for the same molecule, buyer type and lot structure, and from market factors such as the number of likely bidders. They estimate your probability of winning at each price, and you choose the price that maximises expected value, balancing the chance of winning against margin.

All questions

See your own tender results and prices in thirty minutes

We load your products and markets beforehand, so the demo runs on your data.